Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CBAY - CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q1 2022 Results - Earnings Call Transcript

CBAY - CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q1 2022 Results - Earnings Call Transcript

CymaBay Therapeutics Inc.
CymaBay Therapeutics, Inc. (CBAY) Q1 2022 Earnings Conference Call May 12, 2022 16:30 ET Company Participants Paul Quinlan - General Counsel Sujal Shah - Chief Executive Officer Dan Menold - Vice President, Finance Charles McWherter - Chief Scientific Officer Conference Call Participants Steven Seedhouse - Raymond James Patrick Dolezal - LifeSci Capital Ed Arce - H.C. Wainwright Jay Olson - Oppenheimer & Company Michael Kratky - SVB Securities Presentation Operator Good day, ladies and gentlemen and welcome to the CymaBay’s First Quarter 2022 Financial Results and Business Update Conference Call. [Operator Instructions] Please be advised that the call will be recorded at the company’s request. It is also being webcast live on the Investors section at the CymaBay website at www.cymabay.com. Now, I’d like to turn the call over to Mr. Paul Quinlan, General Counsel at CymaBay. Mr. Quinlan, please proceed. Paul Quinlan Thank you, operator, and good afternoon, everyone.

For further details see:

CymaBay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: CymaBay Therapeutics Inc.
Stock Symbol: CBAY
Market: NASDAQ
Website: cymabay.com
Menu
CBAY CBAY Quote CBAY Short CBAY News CBAY Articles CBAY Message Board
Get CBAY Alerts

News, Short Squeeze, Breakout and More Instantly...